Logo
Title
Regulatory Rapporteur April 2022
Summary
Green Pharma - Exploring the green initiatives transforming the industry Plus: Interview: A review of paediatric development challenges, FDA collaboration and future trends Article: Brexit: The regulatory landscape one year on Meeting report: The DIA's accelerating CMC workshop
DocumentAccess
Regulatory Rapporteur April 2022MEMBERS
Electronic leaflet pilot in Belgium and Luxembourg hospitalsMEMBERS
A review of paediatric development challenges, FDA collaboration and future trendsMEMBERS
The EU restriction proposal for intentionally-added microplastics: A focus on solid dosage form medicinal products and food supplementsMEMBERS
Brexit: The regulatory landscape one year onMEMBERS
The DIA's accelerating CMC workshopMEMBERS
Planning for the future: sustainable medical devicesMEMBERS
The national competent authorities of Belgium and Luxembourg share their views about the e-PIL PilotMEMBERS
Terrestrial ecotoxicological studies for veterinary pharmaceuticals in livestock dung in the field: Phase II Tier A and beyondMEMBERS
The future of pharmaceuticals is green PUBLIC